Histologically-confirmed, locally advanced (unresectable) or metastatic solid tumors with recurrence or progression during or after standard therapy, intolerance to standard therapy, refused to receive standard therapy, or for whom no standard therapy is available.
You may not be if
Have spinal cord compression or clinically active central nervous system metastases
Have leptomeningeal disease
Have thromboembolic or clinically significant bleeding events
